The Latin America, Middle East and Africa Proton Therapy Market would witness market growth of 15.1% CAGR during the forecast period (2022-2028).
The therapy was delivered by passive scattering in the first available commercial proton delivery systems. In scattering proton treatment, scattering devices spread out the proton beam, which is then shaped by placing objects like collimators and compensators in the beam's path. The target volume receives a homogenous dosage from passive scattering. Passive scattering hence offers less control over dosage distributions close to the target.
Pencil beam scanning has been included in several scattering therapy systems throughout time. Since scattering therapy was the first type of proton therapy to be made available, scattering technology was used to gather the majority of clinical data on proton therapy, particularly long-term data as of 2020. Pencil beam scanning is a more recent and adaptable delivery technique that employs a beam that sweeps horizontally over the target to give the required dose while closely mimicking the shape of the tumor.
This conformal delivery is accomplished without the use of apertures or compensators by magnetically scanning small proton beamlets to shape the dose. Multiple beams are delivered from various angles, and magnets in the treatment nozzle direct the proton beam as the dose is applied layer by layer to conform to the target volume. The proton dose can be delivered with greater control and flexibility using this sort of scanning delivery, allowing it to perfectly fit the geometry of the tumor.
The United Arab Emirates (UAE), which has one of the fastest-growing economies in the world, has seen an increase in non - communicable disease including cancer. Despite screening and early diagnosis measures that seem to be far from the objective inclusion of the intended respondents, the number of illnesses and deaths in the UAE has been rising over time. The UAE's cancer control strategy is being designed with specific aims and objectives in mind, adhering to the recommendations of the WHO and EMRO. The objectives include treating cancer, lowering cancer incidence, managing mortality, and improving the prognosis and quality of life for cancer patients.
The Brazil market dominated the LAMEA Proton Therapy Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $16,637.2 Thousands by 2028. The Argentina market is anticipated to witness a CAGR of 15.7% during (2022 - 2028). Additionally, The UAE market would witness a CAGR of 14.8% during (2022 - 2028).
Based on Product Type, the market is segmented into Accelerator, Beam Delivery System, Beam Transport System, Nozzle & Image Viewers and Patient Positioning System. Based on Indication, the market is segmented into CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Others. Based on End User, the market is segmented into Hospitals, Proton Therapy Centers and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Proton Therapy Market is Predict to reach $963.6 Million by 2028, at a CAGR of 12.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Toshiba Corporation, Siemens Healthineers AG (Siemens AG), Ion Beam Applications SA, Hitachi, Ltd., Mirion Technologies, Inc., Mevion Medical Systems, Inc., Provision Healthcare, Sumitomo Corporation and Optivus Proton Therapy, Inc.
By Product Type
By Indication
By End User
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 